These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7774855)

  • 21. The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma.
    Bristow RE; Duska LR; Montz FJ
    Gynecol Oncol; 2001 Apr; 81(1):92-9. PubMed ID: 11277657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Uterine papillary serous carcinoma--a different kind of tumor].
    Steinman N; Avni A
    Harefuah; 1999 May; 136(10):810-2. PubMed ID: 10955120
    [No Abstract]   [Full Text] [Related]  

  • 23. Uterine papillary serous carcinoma revisited.
    Hendrickson MR; Longacre TA; Kempson RL
    Gynecol Oncol; 1994 Sep; 54(3):261-3. PubMed ID: 8088601
    [No Abstract]   [Full Text] [Related]  

  • 24. Uterine papillary serous carcinoma (UPSC): a clinicopathologic study of 30 cases.
    Kato DT; Ferry JA; Goodman A; Sullinger J; Scully RE; Goff BA; Fuller AF; Rice LW
    Gynecol Oncol; 1995 Dec; 59(3):384-9. PubMed ID: 8522260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Uterine papillary serous carcinoma--one kind of special type of uterine endometrial carcinoma].
    Wu M; Lang J; Guo L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):3-7. PubMed ID: 8758809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma.
    Thomas MB; Mariani A; Cliby WA; Keeney GA; Podratz KC; Dowdy SC
    Gynecol Oncol; 2007 Nov; 107(2):186-9. PubMed ID: 17688926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Examination by image analysis for determining quantitative DNA parameters of serous papillary adenocarcinoma of the endometrium--a single case analysis].
    Köhler U; Horn LG; Naumann G; Nenning H; Bilek K
    Zentralbl Gynakol; 1995; 117(4):213-6. PubMed ID: 7778358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uterine papillary serous carcinoma in a 32-year-old with Turner's syndrome.
    Woolas RP; Williams K; McCartney AJ
    Gynecol Oncol; 1994 Mar; 52(3):395-401. PubMed ID: 8157198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uterine papillary serous carcinoma: patterns of failure and survival.
    Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V
    Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastatic uterine serous carcinoma originating in an endometrial polyp: a report of 2 cases.
    Childs AJ; Burke JJ; Perry MY; Gallup DG
    J Reprod Med; 2005 Mar; 50(3):209-12. PubMed ID: 15841935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant chemotherapy in uterine papillary serous carcinoma.
    Resnik E; Taxy JB
    Gynecol Oncol; 1996 Jul; 62(1):123-7. PubMed ID: 8690284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
    Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S
    Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Uterine papillary serous carcinoma and papillary endometrial carcinoma: analysis of clinical biological behaviors of 56 cases].
    Sun X; Shi S; Sheng X
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):8-11. PubMed ID: 8758810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma.
    Geisler JP; Sorosky JI; Duong HL; Buekers TE; Geisler MJ; Sood AK; Anderson B; Buller RE
    Gynecol Oncol; 2001 Dec; 83(3):501-3. PubMed ID: 11733962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC).
    Fields AL; Einstein MH; Novetsky AP; Gebb J; Goldberg GL
    Gynecol Oncol; 2008 Jan; 108(1):201-6. PubMed ID: 17997145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.
    Maxwell GL; Chandramouli GV; Dainty L; Litzi TJ; Berchuck A; Barrett JC; Risinger JI
    Clin Cancer Res; 2005 Jun; 11(11):4056-66. PubMed ID: 15930340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas.
    Goldstein NS; Uzieblo A
    Am J Clin Pathol; 2002 Apr; 117(4):541-5. PubMed ID: 11939727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
    Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
    Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma.
    Ben-Baruch G; Sivan E; Moran O; Rizel S; Menczer J; Seidman DS
    Gynecol Oncol; 1996 Mar; 60(3):393-6. PubMed ID: 8774644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of micropapillary serous ovarian carcinoma (the aggressive variant of serous borderline tumors).
    Seidman JD; Kurman RJ
    Cancer; 2002 Aug; 95(4):675-6. PubMed ID: 12209708
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.